Intensive Care Medicine

, Volume 31, Issue 12, pp 1693–1699 | Cite as

The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis

  • Damien du Cheyron
  • Bruno Bouchet
  • Jean-Jacques Parienti
  • Michel Ramakers
  • Pierre Charbonneau
Original

Abstract

Objective

To determine outcome and mortality risk related to acute renal failure (ARF) in critically ill patients with cirrhosis.

Design and setting

A retrospective cohort analysis and two independent case-control analyses in a medical ICU.

Patients

41 and 32 patients who developed mild and severe ARF, respectively, matched (1:2 ratio) with cirrhotic patients without ARF during their ICU stay.

Measurements and results

Cirrhotic patients with ARF had higher MELD, APACHE II, and SOFA scores at baseline that those without ARF. They had more respiratory failure and cardiovascular failure during ICU stay, longer stay in ICU, and a greater crude hospital mortality rate (65% vs. 32%). Multivariate survival analysis identified ARF (hazard ratio, HR, 4.1), alcohol abuse or dependency, and severe sepsis or septic shock as independent predictors of death. In case-control studies both mild and severe ARF were independently associated with mortality (HR, 2.6, and 4.2, respectively). Cirrhotic patients with mild ARF patients had a higher risk of death than those without ARF (relative risk, RR, 2.0). Severe ARF was associated with an increase matched risk of death (RR 2.6), higher mortality of 51%, and higher risk-adjusted mortality rate (2.1 vs. 0.9).

Conclusions

ICU patients with liver cirrhosis still have a high crude mortality. In this specific population ARF is associated with an excess mortality, depending on the severity of renal dysfunction.

Keywords

Cirrhosis Acute renal failure Intensive care unit Outcome 

Supplementary material

supp.pdf (68 kb)
(PDF 68 KB)

References

  1. 1.
    Shellman RG, Fulkerson WJ, DeLong E, Piantadosi CA (1988) Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med 16:671–678PubMedGoogle Scholar
  2. 2.
    Moreau R, Hadengue A, Soupison T, Kirstetter P, Mamzer MF, Vanjak D, Vauquelin P, Assous M, Sicot C (1992) Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med 20:746–750PubMedGoogle Scholar
  3. 3.
    Zimmerman JE, Wagner DP, Seneff MG, Becker RB, Sun X, Knaus WA (1996) Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival. Hepatology 23:1393–1401PubMedGoogle Scholar
  4. 4.
    Singh N, Gayowski T, Wagener MM, Marino IR (1998) Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. J Gastroenterol 33:73–79CrossRefPubMedGoogle Scholar
  5. 5.
    Kress JP, Rubin A, Pohlman AS, Hall JB (2000) Outcomes of critically ill patients denied consideration for liver transplantation. Am J Respir Crit Care Med 162:418–423PubMedGoogle Scholar
  6. 6.
    Wehler M, Kokoska J, Reulbach U, Hahn EG, Strauss R (2001) Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 34:255–261CrossRefPubMedGoogle Scholar
  7. 7.
    Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC (2001) Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest 119:1489–1497CrossRefPubMedGoogle Scholar
  8. 8.
    Gines P, Berl T, Bernardi M, Bichet DG, Hamon G, Jimenez W, Liard JF, Martin PY, Schrier RW (1998) Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology 28:851–864CrossRefPubMedGoogle Scholar
  9. 9.
    Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30:2051–2058CrossRefPubMedGoogle Scholar
  10. 10.
    Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N Engl J Med 334:1448–1460CrossRefPubMedGoogle Scholar
  11. 11.
    Chen YC, Tsai MH, Hsu CW, Ho YP, Lien JM, Chang MY, Fang JT, Huang CC, Chen PC (2003) Role of serum creatinine and prognostic scoring systems in assessing hospital mortality in critically ill cirrhotic patients with upper gastrointestinal bleeding. J Nephrol 16:558–565PubMedGoogle Scholar
  12. 12.
    Moreau R, Lebrec D (2003) Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 37:233–243CrossRefPubMedGoogle Scholar
  13. 13.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829PubMedGoogle Scholar
  14. 14.
    Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710PubMedGoogle Scholar
  15. 15.
    O’Connor PG, Schottenfeld RS (1998) Patients with alcohol problems. N Engl J Med 338:592–602CrossRefPubMedGoogle Scholar
  16. 16.
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470CrossRefPubMedGoogle Scholar
  17. 17.
    Lindahl TL, Egberg N, Hillarp A, Odegaard OR, Edlund B, Svensson J, Sandset PM, Ranby M (2004) INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples. Thromb Haemost 91:1223–1231PubMedGoogle Scholar
  18. 18.
    Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212CrossRefPubMedGoogle Scholar
  19. 19.
    19 (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874PubMedGoogle Scholar
  20. 20.
    Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 25:686–696CrossRefPubMedGoogle Scholar
  21. 21.
    Hosmer DW, Lemeshow S (1995) Confidence interval estimates of an index of quality performance based on logistic regression models. Stat Med 14:2161–2172PubMedGoogle Scholar
  22. 22.
    Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S (1999) Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 20:396–401PubMedGoogle Scholar
  23. 23.
    Rabe C, Schmitz V, Paashaus M, Musch A, Zickermann H, Dumoulin FL, Sauerbruch T, Caselmann WH (2004) Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation. Intensive Care Med 30:1564–1571CrossRefPubMedGoogle Scholar
  24. 24.
    Arabi Y, Ahmed QA, Haddad S, Aljumah A, Al-Shimemeri A (2004) Outcome predictors of cirrhosis patients admitted to the intensive care unit. Eur J Gastroenterol Hepatol 16:333–339CrossRefPubMedGoogle Scholar
  25. 25.
    Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159–169CrossRefPubMedGoogle Scholar
  26. 26.
    Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403–409CrossRefPubMedGoogle Scholar
  27. 27.
    Gines P, Cardenas A, Arroyo V, Rodes J (2004) Management of cirrhosis and ascites. N Engl J Med 350:1646–1654CrossRefPubMedGoogle Scholar
  28. 28.
    Runyon BA (2004) Management of adult patients with ascites due to cirrhosis. Hepatology 39:841–856CrossRefPubMedGoogle Scholar
  29. 29.
    Witzke O, Baumann M, Patschan D, Patschan S, Mitchell A, Treichel U, Gerken G, Philipp T, Kribben A (2004) Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol 19:1369–1373CrossRefPubMedGoogle Scholar
  30. 30.
    Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T (2000) Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47:288–295CrossRefPubMedGoogle Scholar
  31. 31.
    Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Lohr JM, Liebe S, Emmrich J, Korten G, Schmidt R (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6:277–286CrossRefPubMedGoogle Scholar
  32. 32.
    Druml W (2004) Acute renal failure is not a “cute” renal failure! Intensive Care Med 30:1886–1890Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Damien du Cheyron
    • 1
  • Bruno Bouchet
    • 1
  • Jean-Jacques Parienti
    • 2
  • Michel Ramakers
    • 1
  • Pierre Charbonneau
    • 1
  1. 1.Department of Medical Intensive CareCaen University HospitalCaen CedexFrance
  2. 2.Department of Clinical ResearchCaen University HospitalCaen CedexFrance

Personalised recommendations